XSES
H13
Market cap1.05bUSD
Sep 17, Last price
2.01SGD
1D
-0.50%
1Q
-1.95%
Jan 2017
-0.25%
Name
Ho Bee Land Ltd
Chart & performance
P/E
13.32
P/S
3.03
EPS
0.15
Div yield, %
1.99%
Shrs. gr., 5y
-0.03%
Rev. gr., 5y
15.04%
Revenues
440m
-16.66%
Net income
100m
-8.54%
CFO
177m
-36.49%
Dividend
May 12, 20260.05 SGD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Established in 1987, Ho Bee Land Limited operates as a real estate firm. Since its listing on the Singapore Exchange Mainboard in 1999, the company has expanded its presence internationally, with interests across Australia, China, the United Kingdom, and Europe. From its beginnings, its diverse portfolio has encompassed high-quality residential, commercial, and advanced industrial developments. Within Singapore, Ho Bee is widely acclaimed as the trailblazing developer of premium residences in the prestigious Sentosa Cove district. Significant projects in its home market also feature The Metropolis at one-north, currently the largest Grade A office complex located beyond the Central Business District, alongside Elementum, an innovative biomedical sciences facility anticipated for completion by the close of 2023. Its London holdings comprise eight investment properties, among them prominent addresses such as The Scalpel, Ropemaker Place, and 1 St Martin's Le Grand. The firm is dedicated to providing superior homes and structures for its stakeholders and fostering a sustainable built environment.
Key people
Wee Chern Chua
Deputy Chief Executive Officer · since 2018
Woan Chiou Lee
Financial Controller · since 2018
Chong Hua Ong
Executive Director · since 1995
Choon Leng Woon
Executive Director · since 1995
Hock Chang Chong
Group Director - Projects and Marketing · since 2017
Leng Guan Hong
Project Manager · since 2007
Lai Sai Low
Senior Finance Manager · since 2011
Lay Yen Ng
Marketing Manager
Suet Khee Fung
Company Secretary · since 2019
Thian Poh Chua
Executive Chairman of the Board, Chief Executive Officer · since 1987
Cheow Tong Chan
Non-Executive Independent Director · since 2002
Non-Executive Independent Director · since 2006
Poh Hua Choo
Non-Executive Independent Director · since 2017
Kheng Hwa Ko
Non-Executive Independent Director · since 2016
Choke Meng Seow
Non-Executive Independent Director · since 2017
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||